BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pardo-de-Santayana G, Juncal-Ruiz M, Vázquez-Bourgon J, Riesco-Dávila L, Ortiz-Garcia de la Foz V, Pelayo-Terán JM, López-Hoyos M, Crespo-Facorro B. Active psychosis and pro-inflammatory cytokines in first-episode of psychosis. J Psychiatr Res 2021;134:150-7. [PMID: 33385633 DOI: 10.1016/j.jpsychires.2020.12.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 McGrath T, Baskerville R, Rogero M, Castell L. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases. Nutrients 2022;14:917. [PMID: 35267893 DOI: 10.3390/nu14050917] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Kalitin KY, Spasov AA, Mukha OY, Pridvorov GV, Lipatov VA. Pharmacological Targets and Mechanisms of Action of Antipsychotic Substances in the Context of the Neurochemical Theory of the Pathogenesis of Schizophrenia. Neurosci Behav Physi 2022;52:108-123. [DOI: 10.1007/s11055-022-01213-7] [Reference Citation Analysis]
3 North HF, Weissleder C, Fullerton JM, Sager R, Webster MJ, Weickert CS. A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone. Transl Psychiatry 2021;11:635. [PMID: 34911938 DOI: 10.1038/s41398-021-01742-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
4 Prados-Ojeda JL, Luque-Luque R, Gordillo-Urbano RM, Guler I, López-Medina C, Collantes-Estévez E, Escudero-Contreras A. Assessment of Subclinical Psychotic Symptoms in Patients with Rheumatoid Arthritis and Spondyloarthritis. J Clin Med 2021;10:3461. [PMID: 34441756 DOI: 10.3390/jcm10163461] [Reference Citation Analysis]